3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
65
Phase 2
60
Phase NA
29
Phase 1/2
19
Phase EARLY_PHASE1
5
Phase 3
4
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
10
Thoracic
2
Gastrointestinal
2
Breast
2
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Dermatologic
1
CNS
1
Conditions
Glioblastoma
15
Brain Neoplasms
15
Glioma
9
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Neoplasms by Site
5
Neoplasms by Histologic Type
5
Hematologic Neoplasms
5
Recurrence
4
Neuroblastoma
4
Astrocytoma
4
Spinal Cord Neoplasms
3
Lymphoproliferative Disorders
3
Lung Neoplasms
3
Colorectal Neoplasms
3
Thyroid Carcinoma, Anaplastic
2
Thyroid Cancer, Papillary
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neurofibromatosis 1
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Medulloblastoma
2
Lymphoma
2
Laryngeal Neoplasms
2
Erdheim-Chester Disease
2
Central Nervous System Neoplasms
2
cyclopia sequence
1
Vitamin D Deficiency
1
Interventions
capmatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Sarcoma
×
CNS
×
Clear all
NCT06988475
2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
30 enrolled